Blueland Pharmaceutical Private Limited
About Blueland Pharmaceutical Private Limited
Data last updated:
Blueland Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC337835. Its GSTIN is 07AAHCB9654R1ZR (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Abhimanyu Pandey and Gaurav Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No T – 23 Third Floor Malhan Falcon Plaza Plot No – 4 Pocket – 7 Sector – 12 Dwarka, Delhi, India – 110078.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.25 Lakh, a decline of 41% compared to the previous year. For the same year it recorded a net loss of ₹54.5 Lakh (net margin -234.4%) and EBITDA of -₹54.29 Lakh (EBITDA margin -233.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 28% over five years.
Company details
Contact details
Blueland Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressShop No T – 23 Third Floor Malhan Falcon Plaza Plot No – 4 Pocket – 7 Sector – 12 Dwarka, Delhi, India – 110078
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Blueland Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Blueland Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Blueland Pharmaceutical Private Limited, buy the company report.
Financials of Blueland Pharmaceutical Private Limited
FY 2025 filings availableBlueland Pharmaceutical Private Limited reported revenue of ₹23.25 Lakh (down 41% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 41% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 28%. EBITDA fell 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹54.29 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹54.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -233.5% | ||||
| Net Profit Margin | -234.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Blueland Pharmaceutical Private Limited, buy the company report.
Board of directors of Blueland Pharmaceutical Private Limited
Blueland Pharmaceutical has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhimanyu Pandey | Director | 01 Jun 2019 | 7 Years 5 Months | Current |
| Gaurav Pandey | Director | 01 Jun 2019 | 7 Years 5 Months | Current |
Peer comparison
Blueland Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Frameit Eyewear Private Limited | ₹23.32 Lakh (FY 2025) | Adilabad, Telangana, India | ||||
| Apex Vanijya Pvt Ltd | ₹23.32 Lakh (FY 2025) | -46.0% | Kolkata, West Bengal, India | |||
| Balaji Action Wooddecor Private Limited | ₹23.31 Lakh (FY 2025) | 33.0% | Delhi, India | |||
| Pkapo Opulence Private Limited | ₹23.3 Lakh (FY 2024) | Kannauj, Uttar Pradesh, India | ||||
| Jatan Exports Private Limited | ₹23.29 Lakh (FY 2024) | 2200.0% | Kolkata, West Bengal, India | |||
| Blueland Pharmaceutical Private Limitedthis company | ₹23.25 Lakh (FY 2025) | -₹54.5 Lakh | -234.4% | -41.0% | Delhi, India | |
| Bakley Pharmaceuticals Private Limited | ₹23.25 Lakh (FY 2025) | 131.0% | Kichha, Uttarakhand, India | |||
| Camoflex Industries Limited | ₹23.25 Lakh (FY 2024) | 183.0% | Mumbai, Maharashtra, India | |||
| VKND India Private Limited | ₹23.25 Lakh (FY 2025) | Delhi, India | ||||
| Arush Overseas Pvt Ltd | ₹23.23 Lakh (FY 2025) | 79.0% | New Delhi, Delhi, India | |||
| Umarga Shetkari Parisar Producer Company Limited | ₹23.22 Lakh (FY 2024) | Omerga, Maharashtra, India |
To see the full peer comparison of Blueland Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Blueland Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Blueland Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Blueland Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCB9654R1ZR | Delhi | Active | 19 Sep 2018 |
To see the full GST registrations and return filing status of Blueland Pharmaceutical Private Limited, buy the company report.
Recent activity
Blueland Pharmaceutical Private Limited has 6 board changes on record since 2019: 2 appointments and 4 cessations. The latest: Abhimanyu Pandey ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Blueland Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 August 2018 (8+ years old) and is registered under CIN U74999DL2018PTC337835.
Blueland Pharmaceutical has 2 current directors:
- Abhimanyu Pandey - Director
- Gaurav Pandey - Director
The latest financial statements of Blueland Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Blueland Pharmaceutical is 07AAHCB9654R1ZR, registered in Delhi.
The CIN (Corporate Identification Number) of Blueland Pharmaceutical is U74999DL2018PTC337835. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Blueland Pharmaceutical was incorporated on 27 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Blueland Pharmaceutical by revenue are Frameit Eyewear Private Limited, Apex Vanijya Pvt Ltd, Balaji Action Wooddecor Private Limited, Pkapo Opulence Private Limited, Jatan Exports Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Abhimanyu Pandey ceased to be Additional Director on 30 Sep 2019. Gaurav Pandey ceased to be Additional Director on 30 Sep 2019. Abhimanyu Pandey was appointed as Director on 01 Jun 2019. Blueland Pharmaceutical has 6 board changes on record in total.
The registered office of Blueland Pharmaceutical is at Shop No T – 23 Third Floor Malhan Falcon Plaza Plot No – 4 Pocket – 7 Sector – 12 Dwarka, Delhi, India – 110078.
Blueland Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Blueland Pharmaceutical can be reached at its registered office: Shop No T – 23 Third Floor Malhan Falcon Plaza Plot No – 4 Pocket – 7 Sector – 12 Dwarka, Delhi, India – 110078.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
